1. Home
  2. DRUG vs WLKP Comparison

DRUG vs WLKP Comparison

Compare DRUG & WLKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$88.01

Market Cap

707.1M

Sector

Health Care

ML Signal

HOLD

Logo Westlake Chemical Partners LP

WLKP

Westlake Chemical Partners LP

N/A

Current Price

$22.90

Market Cap

778.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
DRUG
WLKP
Founded
2019
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
707.1M
778.9M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
DRUG
WLKP
Price
$88.01
$22.90
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$129.25
N/A
AVG Volume (30 Days)
151.3K
19.6K
Earning Date
05-15-2026
05-05-2026
Dividend Yield
N/A
8.25%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,166,695,000.00
Revenue This Year
N/A
$19.48
Revenue Next Year
N/A
$5.24
P/E Ratio
N/A
$15.30
Revenue Growth
N/A
2.71
52 Week Low
$23.18
$17.75
52 Week High
$123.75
$23.46

Technical Indicators

Market Signals
Indicator
DRUG
WLKP
Relative Strength Index (RSI) 58.20 N/A
Support Level $72.06 N/A
Resistance Level $91.69 N/A
Average True Range (ATR) 3.92 0.00
MACD -0.24 0.00
Stochastic Oscillator 43.59 0.00

Price Performance

Historical Comparison
DRUG
WLKP

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

About WLKP Westlake Chemical Partners LP

Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen, to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.

Share on Social Networks: